Quest Diagnostics Inc's Cash & cash equivalent grew by 83.21 % in the Q2 2026 sequentially, while Current Liabilities decreased, this led to improvement in Quest Diagnostics Inc's Quick Ratio to 0.4, above Quest Diagnostics Inc average Quick Ratio.

Within Medical Laboratories industry 23 other companies have achieved higher Quick Ratio than Quest Diagnostics Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 172 to 2615.

Explain Quick Ratio?
How much Cash & cash equivalents DGX�s has?
What are DGX�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

DGX Quick Ratio	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3	(Jun 30 2025) Q2
Y / Y Current Liabilities Change	114.13 %	57.97 %	5.41 %	2.35 %	-54.94 %
Y / Y Cash & cash equivalent Change	125.71 %	109.04 %	-9.29 %	-43.46 %	17.71 %
Quick Ratio MRQ	0.4	0.2	0.24	0.22	0.38
DGX's Total Ranking	# 2615	# 172	# 2096	# 482	# 650
Seq. Current Liabilities Change	-10.73 %	-4.8 %	7.29 %	134.85 %	-34.15 %
Seq. Cash & cash equivalent Change	83.21 %	-21.08 %	15.28 %	35.42 %	69.68 %

Quick Ratio second quarter 2026 Company Ranking
Within:	No.
Medical Laboratories Industry	# 24
Healthcare Sector	# 748
Overall Market	# 2615

Quick Ratio Statistics
High	Average	Low
0.79	0.25	0.06
(Mar 31 2021)		(Sep. 30, 2011)

Financial Statements
Quest Diagnostics Inc's Current Liabilities	$ 1,788 Millions	Visit DGX's Balance sheet
Quest Diagnostics Inc's Cash & cash equivalent	$ 720 Millions	Visit DGX's Balance sheet
Source of DGX's Sales		Visit DGX's Sales by Geography

Cumulative Quest Diagnostics Inc's Quick Ratio

DGX's Quick Ratio for the trailling 12 Months

DGX Quick Ratio	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months	(Jun 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	30.61 %	-1.85 %	-22.02 %	-21.76 %	-17.49 %
Y / Y Cash & cash equivalent TTM Growth	12.25 %	-7.34 %	-30.17 %	-32.21 %	15.63 %
Quick Ratio TTM	0.26	0.24	0.23	0.25	0.3
Total Ranking TTM	# 4099	# 208	# 2154	# 618	# 3092
Seq. Current Liabilities TTM Growth	13.81 %	11.92 %	1.78 %	0.75 %	-14.47 %
Seq. Cash & cash equivalent TTM Growth	24.42 %	14.27 %	-3.43 %	-18.24 %	2.71 %

Quick ratio ranking by company, industry and sector >> Back to DGX Financial Strength Comparisons >> Go to Compare DGX Quick Ratio to its Competitors

On the trailing twelve months basis DGX Cash & cash equivalent more than doubled by 125.71 % in Q2 2026 year on year, faster than Current Liabilities, this led to increase in in Quest Diagnostics Inc's Quick Ratio to 0.26, above DGX average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Laboratories industry 38 other companies have achieved higher Quick Ratio than Quest Diagnostics Inc. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 208 to 4099.

Explain Quick Ratio?
How much Cash & cash equivalents DGX�s has?
What are DGX�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Laboratories Industry	# 39
Healthcare Sector	# 908
Within the Market	# 4099

trailing twelve months Quick Ratio Statistics
High	Average	Low
0.65	0.24	0.1
(Mar 31 2021)		(June 30. 2012)

Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Laboratories Industry	Quick Ratio	Jun 30 2026 MRQ Cash & cash equivalent	Jun 30 2026 MRQ Current Liabilities
Bioaffinity Technologies Inc	0.91	$ 2.430 Millions	$ 2.681 Millions
Ispecimen inc	0.43	$ 4.426 Millions	$ 10.196 Millions
Quest Diagnostics Inc	0.40	$ 720.000 Millions	$ 1,788.000 Millions
Lumexa Imaging Holdings Inc	0.39	$ 69.705 Millions	$ 178.355 Millions
Medpace Holdings Inc	0.35	$ 502.688 Millions	$ 1,435.429 Millions
American Shared Hospital Services	0.30	$ 6.761 Millions	$ 22.424 Millions
Nuo Therapeutics, Inc.	0.29	$ 0.449 Millions	$ 1.554 Millions
Icon Plc	0.24	$ 930.885 Millions	$ 3,934.665 Millions
Fortrea Holdings Inc	0.17	$ 168.600 Millions	$ 963.700 Millions
Charles River Laboratories International inc	0.17	$ 192.025 Millions	$ 1,134.746 Millions
Nrc Health	0.10	$ 3.327 Millions	$ 35.019 Millions

Date modified: 2026-09-08T17:24:43+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.